Khosla, VCs Plow $100 Million Into Blood Test Startup Using AI
Karius’ technology is already being used to test patients’ blood for infections.
This article is for subscribers only.
Blood-testing company Karius Inc. raised $100 million in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals.
The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation.